https://ml-eu.globenewswire.com/Resource/Download/086e4383-01c6-4a7f-a5d5-6f436b3f2643
BTIG Maintains Buy on Treace Medical Concepts, Raises Price Target to $28
BTIG analyst Ryan Zimmerman maintains Treace Medical Concepts (NASDAQ:TMCI) with a Buy and raises the price target from $23 to $28.